This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chiorazzi N, Rai KR, Ferrarini M . Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804–815.
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1910–1916.
Brown JR, Levine RL, Thompson C, Basile G, Gilliland DG, Freedman AS . Systematic genomic screen for tyrosine kinase mutations in CLL. Leukemia 2008; 22: 1966–1969.
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524–15529.
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S . The protein kinase complement of the human genome. Science (New York, NY) 2002; 298: 1912–1934.
Kujawski L, Ouillette P, Erba H, Saddler C, Jakubowiak A, Kaminski M et al. Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia. Blood 2008; 112: 1993–2003.
Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ et al. The genomic landscapes of human breast and colorectal cancers. Science (New York, NY) 2007; 318: 1108–1113.
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949–954.
Carter H, Chen S, Isik L, Tyekucheva S, Velculescu VE, Kinzler KW et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res 2009; 69: 6660–6667.
Carter H, Samayoa J, Hruban RH, Karchin R . Prioritization of driver mutations in pancreatic cancer using cancer-specific high-throughput annotation of somatic mutations (CHASM). Cancer biol ther 2010; 10: 582–587.
Amit YaG D . Shape quantization and recognition with random trees. Neural Comput 1997; 9: 1545–1588.
Breiman L . Random Forest. Machine Learning 2001; 45: 5–32.
Forbes SA, Tang G, Bindal N, Bamford S, Dawson E, Cole C et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 2010; 38 (Database issue): D652–D657.
Backert S, Gelos M, Kobalz U, Hanski ML, Bohm C, Mann B et al. Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array. Int J Cancer 1999; 82: 868–874.
Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE . Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 2002; 418: 934.
Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455: 1069–1075.
Garnett MJ, Rana S, Paterson H, Barford D, Marais R . Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. Mol cell 2005; 20: 963–969.
Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 2004; 116: 855–867.
Acknowledgements
This study was supported by the Virginia and DK Ludwig Fund for Cancer Research, National Institutes of Health Grants CA136537 (SNM), CA135877 (RK), CA 43460 (BV), the Translational Research Program of the Leukemia and Lymphoma Society of America (SM), NSF Grant DBI 0845275 (RK), DOD NDSEG fellowship 32 CFR 168a (HC) and the University of Michigan′s Cancer Center Support Grant (5 P30 CA46592). We are grateful for services provided by the microarray core of the University of Michigan Comprehensive Cancer Center.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Zhang, X., Reis, M., Khoriaty, R. et al. Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia. Leukemia 25, 1908–1910 (2011). https://doi.org/10.1038/leu.2011.163
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.163
This article is cited by
-
The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia
Oncogene (2013)
-
Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34
Leukemia (2012)
-
Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas
Modern Pathology (2012)
-
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Nature Genetics (2012)